Vimarsana
Biggest News Aggregation in the World

Page 5 - Precision Flow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Flow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Flow Today - Breaking & Trending Today

Vapotherm (NYSE:VAPO) Shares Set to Reverse Split on Friday, August 18th - Vimarsana News

Vapotherm (NYSE:VAPO) Shares Set to Reverse Split on Friday, August 18th

Vapotherm, Inc. (NYSE:VAPO – Free Report)’s stock is scheduled to reverse split on Friday, August 18th. The 1-8 reverse split was announced on Friday, August 18th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, August 18th. Vapotherm Price Performance Shares of VAPO opened at $0.41 on Monday. […]

Vapotherm Reports Second Quarter 2023 Financial Results - Vimarsana News

Vapotherm Reports Second Quarter 2023 Financial Results

EXETER, N.H.--(BUSINESS WIRE)--Aug 8, 2023--

Vapotherm To Report Second Quarter 2023 Financial Results - Vimarsana News

Vapotherm To Report Second Quarter 2023 Financial Results

EXETER, N.H.--(BUSINESS WIRE)--Jul 25, 2023--

Vapotherm To Report Second Quarter 2023 Financial Results - Vapotherm (NYSE:VAPO) - Vimarsana News

Vapotherm To Report Second Quarter 2023 Financial Results - Vapotherm (NYSE:VAPO)

Vapotherm, Inc. (NYSE:VAPO), ("Vapotherm" or the "Company"), today announced that it will release financial results for the second quarter of 2023 after the close of trading on Tuesday, August 8, 2023. Vapotherm's

Critical Analysis: Vapotherm (NYSE:VAPO) versus Cochlear (OTCMKTS:CHEOF) - Vimarsana News

Critical Analysis: Vapotherm (NYSE:VAPO) versus Cochlear (OTCMKTS:CHEOF)

Vapotherm (NYSE:VAPO – Get Rating) and Cochlear (OTCMKTS:CHEOF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Valuation & Earnings This table compares Vapotherm and Cochlear’s revenue, earnings per […]